IRhythm outlines $880M-$890M 2026 revenue outlook as it targets 13%-14% adjusted EBITDA margin and plans Vital Connect close by year-end (NASDAQ:IRTC)
· seekingalpha.com
iRhythm (IRTC) Q2 2026 earnings call recap: 20%+ growth, raised 2026 guidance, and Vital Connect acquisition impact, outlook, and risks—read now.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...